ISO/TC 212
Registration number (WIID) | Project No. | Title | Status |
---|---|---|---|
78110 | ISO 20184-3:2021 | Molecular in vitro diagnostic examinations — Specifications for pre-examination processes for frozen tissue — Part 3: Isolated DNA | Standarts spēkā |
79377 | ISO 20776-2:2021 | Clinical laboratory testing and in vitro diagnostic test systems — Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices — Part 2: Evaluation of performance of antimicrobial susceptibility test devices against reference broth micro-dilution | Standarts spēkā |
79378 | ISO 17593:2022 | Clinical laboratory testing and in vitro medical devices — Requirements for in vitro monitoring systems for self-testing of oral anticoagulant therapy | Standarts spēkā |
79379 | ISO 16256:2021 | Clinical laboratory testing and in vitro diagnostic test systems — Broth micro-dilution reference method for testing the in vitro activity of antimicrobial agents against yeast fungi involved in infectious diseases | Standarts spēkā |
81506 | ISO 5649:2024 | Medical laboratories — Concepts and specifications for the design, development, implementation and use of laboratory-developed tests | Standarts spēkā |
81712 | ISO/TS 5798:2022 | In vitro diagnostic test systems — Requirements and recommendations for detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by nucleic acid amplification methods | Atcelts |
83565 | ISO 21474-3:2024 | In vitro diagnostic medical devices — Multiplex molecular testing for nucleic acids — Part 3: Interpretation and reports | Standarts spēkā |
83899 | ISO/WD TS 8219 | Sequencing and clinical application to infectious diseases | Izstrādē |
84816 | ISO/TS 16766:2024 | Manufacturers’ considerations for in vitro diagnostic medical devices in a public health emergency | Standarts spēkā |
85074 | ISO/NP TS 17849 | Guidance on the validation and verification of quantitative and qualitative methods | Izstrādē |
Displaying 101-110 of 142 results.